Overseas acquisitions: Indian drugmakers shop for deals abroad as they move away from generics
Summary
Global uncertainties over the past two years, including US President Donald Trump’s tariff threats, price erosion in the generics market, and a Big Pharma shi...
Description
Global uncertainties over the past two years, including US President Donald Trump’s tariff threats, price erosion in the generics market, and a Big Pharma shi...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source